Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cipla
Merck
Julphar
Fuji
Johnson and Johnson

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 9,181,340

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,181,340
Title:TEM8 antibodies, conjugates thereof, and their use
Abstract: Antibodies that specifically bind TEM8 protein, and conjugates thereof, are disclosed herein. In some examples the conjugates and antibodies are useful for methods of detecting and treating pathogenic angiogenesis. In other examples the conjugates and antibodies are useful for methods of detecting and treating cancer. In additional examples, the conjugates and antibodies are useful for methods of decreasing binding of Anthrax protective antigen to a cell.
Inventor(s): St. Croix; Brad (Frederick, MD), Fleming; Tony (Stow, MA), Chaudhary; Amit (Frederick, MD), Saha; Saurabh (Leawood, KS), Zhang; Xiaoyan Michelle (Lexington, MA), Kwong; Rou-fun (Cambridge, MA), Hilton; Mary Beth (Thurmont, MD)
Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) Novartis AG (Basel, CH)
Application Number:14/126,372
Patent Claims:see list of patent claims

Details for Patent 9,181,340

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) Novartis AG (Basel, CH) 2031-06-14 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) Novartis AG (Basel, CH) 2031-06-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,181,340

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2012172495 Dec 20, 2012
World Intellectual Property Organization (WIPO) 2012174160 Dec 20, 2012
United States of America 2014134179 May 15, 2014
Japan 2014524902 Sep 25, 2014
European Patent Office 2721071 Apr 23, 2014
European Patent Office 2721071 Jan 21, 2015
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Healthtrust
McKinsey
Fish and Richardson
Daiichi Sankyo
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.